Armata Pharmaceuticals (ARMP) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 24.11% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 12.18% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3.92% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -8.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.56% |
| Dec 31, 2025 | -7.91% |
| Sep 30, 2025 | -7.76% |
| Jun 30, 2025 | -6.06% |
| Mar 31, 2025 | 1.44% |
| Dec 31, 2024 | 5.43% |
| Sep 30, 2024 | 47.20% |
| Jun 30, 2024 | 52.99% |
| Mar 31, 2024 | 133.58% |
| Dec 31, 2023 | 247.22% |
| Sep 30, 2023 | 113.13% |
| Jun 30, 2023 | 170.49% |
| Mar 31, 2023 | 141.75% |
| Dec 31, 2022 | 62.93% |
| Sep 30, 2022 | 105.98% |
| Jun 30, 2022 | 53.22% |
| Mar 31, 2022 | 6.34% |
| Dec 31, 2021 | 8.45% |
| Sep 30, 2021 | 8.05% |
| Jun 30, 2021 | 6.46% |
| Mar 31, 2021 | 5.49% |
| Dec 31, 2020 | -6.40% |
| Sep 30, 2020 | -22.92% |
| Jun 30, 2020 | -41.84% |
| Mar 31, 2020 | 377.38% |
| Dec 31, 2019 | -32.69% |
| Sep 30, 2019 | 328.09% |
| Jun 30, 2019 | 406.19% |
| Mar 31, 2019 | -42.23% |
| Dec 31, 2018 | 298.16% |
| Sep 30, 2018 | -30.22% |
| Jun 30, 2018 | -25.41% |
| Mar 31, 2018 | -25.97% |
| Dec 31, 2017 | -23.88% |
| Sep 30, 2017 | -26.48% |
| Jun 30, 2017 | -24.88% |
| Mar 31, 2017 | -16.07% |
| Dec 31, 2016 | -5.22% |
| Sep 30, 2016 | -0.86% |
| Jun 30, 2016 | 5.49% |